$ONTO
ONTO INNOVATION INC.

2017 Q3 Form 10-Q Financial Statement

#000156459017015438 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q2 2015 Q4
Revenue $56.68M $55.77M $42.70M
YoY Change -3.45% 14.68% 7.56%
Cost Of Revenue $30.80M $5.164M $21.90M
YoY Change 8.83% -79.64% -2.23%
Gross Profit $33.60M $50.60M $20.80M
YoY Change 10.53% 117.52% 20.23%
Gross Profit Margin 59.29% 90.74% 48.71%
Selling, General & Admin $13.80M $13.58M $12.70M
YoY Change 2.22% 7.99% 1.6%
% of Gross Profit 41.07% 26.83% 61.06%
Research & Development $9.100M $7.511M $7.800M
YoY Change 15.19% -7.92% -3.7%
% of Gross Profit 27.08% 14.84% 37.5%
Depreciation & Amortization $1.600M $1.700M $2.300M
YoY Change -5.88% 0.0% 109.09%
% of Gross Profit 4.76% 3.36% 11.06%
Operating Expenses $23.18M $21.09M $20.50M
YoY Change 8.81% 1.61% 0.0%
Operating Profit $7.484M $7.336M $300.0K
YoY Change -17.76% 192.39% -109.38%
Interest Expense $25.00K $67.00K $0.00
YoY Change -125.0% -19.28% -100.0%
% of Operating Profit 0.33% 0.91% 0.0%
Other Income/Expense, Net $36.00K -$449.0K $100.0K
YoY Change -82.0% 29.02% -66.67%
Pretax Income $7.520M $6.887M -$1.000M
YoY Change -18.26% 218.7% -72.22%
Income Tax $1.756M $856.0K $800.0K
% Of Pretax Income 23.35% 12.43%
Net Earnings $5.764M $6.031M -$1.800M
YoY Change -27.04% 348.74% -60.87%
Net Earnings / Revenue 10.17% 10.81% -4.22%
Basic Earnings Per Share $0.23 $0.25
Diluted Earnings Per Share $0.22 $0.24 -$74.38K
COMMON SHARES
Basic Shares Outstanding 25.49M 24.52M 24.19M shares
Diluted Shares Outstanding 25.93M 24.93M

Balance Sheet

Concept 2017 Q3 2016 Q2 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.7M $96.00M $83.10M
YoY Change 14.51% 28.34% -1.07%
Cash & Equivalents $44.04M $60.03M $38.15M
Short-Term Investments $93.30M $36.00M $44.90M
Other Short-Term Assets $8.900M $6.800M $6.600M
YoY Change 53.45% -17.07% -38.89%
Inventory $50.50M $50.70M $47.75M
Prepaid Expenses
Receivables $47.00M $54.10M $37.83M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $242.1M $207.6M $178.1M
YoY Change 15.73% 21.68% 12.84%
LONG-TERM ASSETS
Property, Plant & Equipment $42.00M $43.50M $44.49M
YoY Change -5.19% -8.5% -10.36%
Goodwill $9.415M
YoY Change -10.28%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.20M $1.800M $533.0K
YoY Change 911.11% 232.72% -4.65%
Total Long-Term Assets $70.30M $56.00M $57.43M
YoY Change 24.65% -8.11% -12.18%
TOTAL ASSETS
Total Short-Term Assets $242.1M $207.6M $178.1M
Total Long-Term Assets $70.30M $56.00M $57.43M
Total Assets $312.4M $263.6M $235.5M
YoY Change 17.62% 13.84% 5.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.90M $11.00M $11.68M
YoY Change 73.26% -17.65% 14.47%
Accrued Expenses $16.00M $15.70M $15.30M
YoY Change -7.51% 8.28% 14.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.20M $57.10M $45.21M
YoY Change -1.53% 33.94% 18.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.000M $1.800M $878.0K
YoY Change -16.67% 46.82% -31.35%
Total Long-Term Liabilities $2.000M $1.800M $878.0K
YoY Change -16.67% 46.82% -31.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.20M $57.10M $45.21M
Total Long-Term Liabilities $2.000M $1.800M $878.0K
Total Liabilities $47.30M $59.60M $48.21M
YoY Change -3.47% 26.56% 10.33%
SHAREHOLDERS EQUITY
Retained Earnings -$66.21M
YoY Change -4.2%
Common Stock $275.9M $258.7M
YoY Change 2.74% 1077979.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $265.1M $204.0M $187.3M
YoY Change
Total Liabilities & Shareholders Equity $312.4M $263.6M $235.5M
YoY Change 17.62% 13.84% 5.51%

Cashflow Statement

Concept 2017 Q3 2016 Q2 2015 Q4
OPERATING ACTIVITIES
Net Income $5.764M $6.031M -$1.800M
YoY Change -27.04% 348.74% -60.87%
Depreciation, Depletion And Amortization $1.600M $1.700M $2.300M
YoY Change -5.88% 0.0% 109.09%
Cash From Operating Activities $7.200M $12.70M -$700.0K
YoY Change -65.55% -1076.92% -107.87%
INVESTING ACTIVITIES
Capital Expenditures -$1.500M -$1.900M -$400.0K
YoY Change 87.5% 280.0% -86.67%
Acquisitions
YoY Change
Other Investing Activities -$10.70M $8.700M -$2.100M
YoY Change -76.33% 1350.0% 90.91%
Cash From Investing Activities -$12.20M $6.800M -$2.500M
YoY Change -73.48% -39.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.700M 0.000
YoY Change -100.0% -666.67% -100.0%
NET CHANGE
Cash From Operating Activities 7.200M 12.70M -700.0K
Cash From Investing Activities -12.20M 6.800M -2.500M
Cash From Financing Activities 0.000 1.700M 0.000
Net Change In Cash -5.000M 21.20M -3.200M
YoY Change -78.17% -1425.0% 433.33%
FREE CASH FLOW
Cash From Operating Activities $7.200M $12.70M -$700.0K
Capital Expenditures -$1.500M -$1.900M -$400.0K
Free Cash Flow $8.700M $14.60M -$300.0K
YoY Change -59.91% -1925.0% -102.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
nano Transfer Of Property Plant And Equipment To Inventory Net
TransferOfPropertyPlantAndEquipmentToInventoryNet
550000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-527000
nano Transfer Of Property Plant And Equipment To Inventory Net
TransferOfPropertyPlantAndEquipmentToInventoryNet
278000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
275908000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
30145000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45539000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
23506000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10347000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4984000
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87557000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21878000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1837000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10258000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
387000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1863000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60032000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-430000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4708000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38154000
nano Proceeds From Accounts Receivable
ProceedsFromAccountsReceivable
19400000
CY2017Q3 nano Due From Unrelated Third Parties
DueFromUnrelatedThirdParties
0
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28556000
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14692000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5614000
CY2017Q3 nano Inventory
Inventory
50536000
nano Amortization Expense Finite Lived Intangible Assets
AmortizationExpenseFiniteLivedIntangibleAssets
100000
nano Amortization Expense Finite Lived Intangible Assets
AmortizationExpenseFiniteLivedIntangibleAssets
900000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2429000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2377000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
357000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
328236
us-gaap Fiscal Period
FiscalPeriod
<div> <p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Fiscal Period<font style="font-style:normal;"> &#8211; The Company uses a </font><font style="font-style:normal;">52/53 week fiscal year ending on the last Saturday of the calendar year. All references to the quarter refer to Nanometrics&#8217; fiscal quarter. The fiscal quarters reported herein are 13 week periods.</font></p></div>
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates<font style="font-style:normal;"> &#8211; The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates. Estimates are used for, but not limited to, revenue recognition, the provision for doubtful accounts, the provision for excess, obsolete, or slow moving inventories, valuation of intangible and long-lived assets, warranty accruals, income taxes, valuation of stock-based compensation, and contingencies.</font></p></div>
us-gaap Fiscal Period Duration
FiscalPeriodDuration
P91D
nano Maximum Period Of Delivery To Customers
MaximumPeriodOfDeliveryToCustomers
P6M
nano Maximum Period Services Provided Over Fixed Arrangement Term
MaximumPeriodServicesProvidedOverFixedArrangementTerm
P12M
CY2017Q3 nano Fair Value Assets Among Level One Level Two And Level Three Transfers Amount
FairValueAssetsAmongLevelOneLevelTwoAndLevelThreeTransfersAmount
0
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
135718000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
129959000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
34000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
129961000
nano Investment Maturity Period Maximum
InvestmentMaturityPeriodMaximum
P2Y
CY2016 nano Investment Maturity Period Maximum
InvestmentMaturityPeriodMaximum
P2Y
CY2016Q2 nano Proceeds From Accounts Receivable
ProceedsFromAccountsReceivable
5200000
nano Proceeds From Accounts Receivable
ProceedsFromAccountsReceivable
9400000
CY2017Q3 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
0
CY2016Q2 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
0
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
0
us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
0
CY2016Q4 nano Due From Unrelated Third Parties
DueFromUnrelatedThirdParties
0
CY2016Q4 nano Inventory
Inventory
41294000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86545000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42319000
CY2017Q3 us-gaap Depreciation
Depreciation
1600000
CY2017Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4602000
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3838000
CY2016Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
581000
CY2017Q3 nano Retrofit Liability Current
RetrofitLiabilityCurrent
613000
CY2016Q4 nano Retrofit Liability Current
RetrofitLiabilityCurrent
432000
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
720000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
424000
CY2017Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
60000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1233000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1400000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1373000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1539000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
816000
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29836000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
29307000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28895000
CY2017Q3 nano Amortization Expense Finite Lived Intangible Assets
AmortizationExpenseFiniteLivedIntangibleAssets
100000
CY2016Q2 nano Amortization Expense Finite Lived Intangible Assets
AmortizationExpenseFiniteLivedIntangibleAssets
400000
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
103000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
140000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
66000
CY2017Q3 nano Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
0
nano Product Warranty Period
ProductWarrantyPeriod
P12M
CY2017Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4244000
CY2016Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4377000
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4504000
CY2017Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1411000
CY2016Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1368000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2780000
CY2017Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1053000
CY2016Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1189000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2016000
CY2017Q3 nano Intellectual Property Indemnification Obligations
IntellectualPropertyIndemnificationObligations
0
CY2016Q4 nano Intellectual Property Indemnification Obligations
IntellectualPropertyIndemnificationObligations
0
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
599000
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
403000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
660000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
440545
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
111871
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
438
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
328236
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.66
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.60
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.20
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.20
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M3D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M3D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4405000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3313000
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3313000
CY2017Q2 nano Share Based Compensation Arrangements By Share Based Payment Award Options Share Closing Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsShareClosingPrice
25.29
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
600000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1500000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2163000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1743000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4327000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3432000
CY2017Q3 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
400000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q3 us-gaap Noncurrent Assets
NoncurrentAssets
42018000
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
44226000

Files In Submission

Name View Source Status
0001564590-17-015438-index-headers.html Edgar Link pending
0001564590-17-015438-index.html Edgar Link pending
0001564590-17-015438.txt Edgar Link pending
0001564590-17-015438-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nano-10q_20170701.htm Edgar Link pending
nano-20170701.xml Edgar Link completed
nano-20170701.xsd Edgar Link pending
nano-20170701_cal.xml Edgar Link unprocessable
nano-20170701_def.xml Edgar Link unprocessable
nano-20170701_lab.xml Edgar Link unprocessable
nano-20170701_pre.xml Edgar Link unprocessable
nano-ex311_7.htm Edgar Link pending
nano-ex312_6.htm Edgar Link pending
nano-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending